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It is well established that excitation contraction (EC)
coupling in cardiac myocytes is mediated by the entry
of calcium ions (Ca
 
2
 
 
 
) from the bathing medium into
the cell cytoplasm (Fabiato, 1985), which then triggers
calcium-induced calcium release (CICR) from the sar-
coplasmic reticulum (SR). More recently, it was pro-
posed that a second, quite separate, EC-coupling pro-
cess, mediated by an effect of membrane potential per
se on SR Ca
 
2
 
 
 
 release, also operates in cardiac myocytes
(Ferrier and Howlett, 1995; Hobai et al., 1997; Howlett
and Ferrier, 1997; Howlett et al., 1998, 1999; Ferrier et
al., 1998, 2000; Mason and Ferrier, 1999; Zhu and Fer-
rier, 2000; for review see Ferrier and Howlett, 2001). Al-
though a substantial body of diverse experimental ob-
servations has been reported in support of this voltage-
sensitive release mechanism (VSRM; Ferrier and Howlett,
2001), it remains highly controversial (Nabauer et al.,
1989; Wier and Balke, 1999; Piacentino et al., 2000; Si-
pido, 2003; Trafford and Eisner, 2003).
One reason for reservations regarding VSRM is that
it is said to be observable only under very restricted
conditions: very negative holding potentials, tempera-
tures near 37
 
 
 
C, a fully loaded SR, and, for internally
dialyzed cells, in the presence of agents that promote
protein kinase A (PKA)-mediated phosphorylation.
These conditions all increase either L-type Ca
 
2
 
 
 
 cur-
rents (I
 
Ca(L)
 
) or SR Ca
 
2
 
 
 
 release. Hence, conditions
purported to demonstrate VSRM could, instead, just be
enhancing CICR. A further problem is that whereas
nominally Ca
 
2
 
 
 
-free bathing media fully abolish con-
traction, contraction is restored with as little as 50 
 
 
 
M
external Ca
 
2
 
 
 
 (Ferrier and Howlett, 1995). Ferrier and
Howlett (1995) have taken this result to indicate that a
small amount of external Ca
 
2
 
 
 
 is required as a kind of
cofactor for VSRM, as opposed to actual Ca
 
2
 
 
 
 entry.
However, the observation could equally well indicate
that only little Ca
 
2
 
 
 
 entry is needed to trigger SR Ca
 
2
 
 
 
release, especially under conditions of high SR load.
Moreover, much of the evidence presented in support
of VSRM amounts to the repeated claim, under a vari-
ety of conditions and in a number of different contexts,
that contraction is observed in the absence of detect-
able inward Ca
 
2
 
 
 
 current. If a Ca
 
2
 
 
 
 current actually was
present, but just unrecognized, much of the presump-
tive evidence for VSRM would vanish. Consequently,
despite the many observations reported to be in sup-
port of VSRM, it remains unclear whether VSRM oper-
ates at all in cardiac myocytes.
In this issue, Grifﬁths and MacLeod (2003) make a
solid contribution to the resolution of this controversy,
by showing that inward Ca
 
2
 
 
 
 currents are present un-
der conditions similar to those in some previous studies
where Ca
 
2
 
 
 
 currents were reported to be absent. Specif-
ically, Grifﬁths and MacLeod show that: (a) nifedipine-
sensitive difference currents can be demonstrated for
small depolarizing voltage steps even when I
 
Ca(L)
 
 is not
obvious in the unsubtracted current traces; (b) inward
I
 
Ca(L)
 
 can be unmasked by block of outward current
components; and (c) repolarization-activated tail con-
tractions can be seen during hyperpolarizing post
pulses, demonstrating that conducting, unblocked
Ca
 
2
 
 
 
 channels may be present even when inward cur-
rent during the test step is not evident. These new ﬁnd-
ings present a challenge to VSRM, as they call into
question the core claim behind VSRM, that contrac-
tions can be observed in the absence of inward Ca
 
2
 
 
 
currents. It therefore is of interest to examine some of
the observations reported in support of VSRM in the
light of the new results of Grifﬁths and MacLeod
(2003)—as well as other relevant observations. While a
number of the observations presented as demonstrat-
ing or suggesting VSRM are consistent with CICR, oth-
ers are less obviously so.
Evidence supporting VSRM has been reported pri-
marily by a single group, that of G.R. Ferrier, S.E.
Howlett, and their collaborators. Some of the key ob-
servations of the Ferrier-Howlett group are:
(1) Ferrier and Howlett report that contractions can
be initiated at membrane potentials negative to those
at which I
 
Ca(L)
 
 apparently is activated and that the con-
tractions are increased by holding potentials negative
to 
 
 
 
40 mV, in the range of 
 
 
 
65 to 
 
 
 
70 mV (Ferrier
and Howlett, 1995; Ferrier et al., 1998; Mason and Fer-
rier, 1999). Ferrier and Howlett interpreted these re-
sults as indicating that there must be a VSRM, which is
inactivated at holding potentials positive to 
 
 
 
40 mV.T
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Grifﬁths and MacLeod (2003) conﬁrm that more nega-
tive holding potentials do shift the contraction thresh-
old in the negative direction. However, Grifﬁths and
MacLeod (2003) show that there is also a negative shift
in the potential at which I
 
Ca(L)
 
 is ﬁrst detectable (as did
Ferrier and Howlett [1995] themselves). Rather than
promoting recovery from inactivation of the putative
VSRM, more negative holding potentials simply in-
crease I
 
Ca(L)
 
. The I
 
Ca(L)
 
 availability curve is just not satu-
rated at 
 
 
 
40 mV. Moreover, Grifﬁths and MacLeod
(2003), in addition to their own experiments, cite a
number of previous studies showing that I
 
Ca(L)
 
 can be
elicited at test potentials negative to 
 
 
 
40 mV. Hence
the core claim for VSRM, that contractions are seen in
the absence of inward Ca
 
2
 
 
 
 current, is not supported
when more stringent methods for detecting Ca
 
2
 
 
 
 cur-
rent are employed.
(2) Ferrier and Howlett have reported multiple times
that Ca
 
2
 
 
 
 channel blockers (verapamil, Cd
 
2
 
 
 
, ni-
fedipine, Ni
 
2
 
 
 
) suppress I
 
Ca(L)
 
 substantially (or com-
pletely) with little or no effect on contraction or the
Ca
 
2
 
 
 
 transient at more negative potentials (Ferrier and
Howlett, 1995; Hobai et al., 1997; Howlett and Ferrier,
1997; Ferrier et al., 1998; Howlett et al., 1998; Zhu and
Ferrier, 2000). The block of I
 
Ca(L)
 
, but not contraction,
was seen for voltage steps to 
 
 
 
40 mV from a holding
potential of 
 
 
 
65 mV (conditions selective for the puta-
tive VSRM: recovery of VSRM from inactivation has oc-
curred, and there is only little I
 
Ca(L)
 
 activation), but not
for steps to 0 mV from a 200–300-ms prestep to –40 mV
(conditions selective for CICR: VSRM is inactivated,
and there is about maximal I
 
Ca(L)
 
). Ferrier and Howlett
took these results to indicate that there must be a
VSRM and that it has a pharmacological proﬁle distinct
from CICR. However, using block of outward current
components and demonstration of repolarization acti-
vated tail contractions, Grifﬁths and MacLeod (2003)
show that I
 
Ca(L)
 
 persists under conditions where the Fer-
rier and Howlett group had taken it to be fully blocked
(by 100 or 300 
 
 
 
M Cd
 
2
 
 
 
, 2.5 
 
 
 
M nifedipine, and 200
 
 
 
M or sometimes 5 mM Ni
 
2
 
 
 
). Grifﬁths and MacLeod
(2003) ﬁnd that I
 
Ca(L)
 
 is not completely blocked by 200
 
 
 
M Cd
 
2
 
 
 
 or 60 
 
 
 
M nifedipine. They found 12 mM Ni
 
2
 
 
 
would fully suppress I
 
Ca(L)
 
 and that such concentrations
also fully suppress contraction under all conditions
tested. Grifﬁths and MacLeod (2003) also cite previous
studies showing that both dihydropyridine and heavy
metal cations block of Ca
 
2
 
 
 
 channels is voltage depen-
dent, being less effective at both more negative holding
potentials and more negative test steps. The important
point is that a distinct pharmacological proﬁle for the
putative VSRM has not been demonstrated.
(3) Ferrier and Howlett report that at more negative
holding potentials, in the range of 
 
 
 
55 to 
 
 
 
65 mV,
the contraction-voltage curve becomes sigmoid and
approximately plateaus near 
 
 
 
20 mV (Ferrier and
Howlett, 1995; Howlett et al., 1998, 1999; Ferrier et al.,
1998, 2000; Mason and Ferrier, 1999). This is in con-
trast to the bell-shaped contraction-voltage curve ob-
tained at holding potentials of 
 
 
 
40 mV, which rises to a
maximum and then declines again at more positive po-
tentials. In the case of the bell-shaped curve the con-
traction amplitude is approximately proportional to
I
 
Ca(L)
 
 amplitude, consistent with CICR. In the case of
the sigmoid curve it is not, and Ferrier and Howlett
have taken this as strong evidence for VSRM. However,
Grifﬁths and MacLeod (2003) were unable to repro-
duce the conversion of the contraction-voltage curve
from bell-shaped to sigmoid with more negative hold-
ing potentials. The curve remained approximately bell-
shaped at all holding potentials tested (see also Beuck-
elmann and Wier, 1988). This is an unresolved issue,
however, as bell-shaped contraction voltage curves are
not always seen (see 
 
discussion
 
 in Grifﬁths and
MacLeod, 2003). There may be a broad maximum, and
the reasons for this may be complex. Gain (the amount
of SR Ca
 
2
 
 
 
 release produced by a given I
 
Ca(L)
 
) is not
constant over the whole voltage range, and reverse
mode Na
 
 
 
-Ca
 
2
 
 
 
 exchange may play a role at large posi-
tive potentials (Sipido et al., 1997).
(4) Ferrier and Howlett report that under conditions
of internal cell dialysis, such as whole cell patch clamp
recording, VSRM is selectively lost. It is said to be re-
stored with internal adenosine 3
 
 
 
, 5
 
 
 
-cyclic monophos-
phate (cAMP), which promotes PKA-mediated protein
phosphorylation (Hobai et al., 1997; Ferrier et al.,
1998). Ferrier et al. (1998) report that cAMP increases
contraction amplitude substantially under VSRM-selec-
tive conditions, but without any accompanying increase
in I
 
Ca(L)
 
. Under CICR-selective conditions, contraction
and I
 
Ca(L)
 
 both increase moderately. Ferrier et al.
(1998) take these ﬁndings as further evidence for
VSRM (increase in contraction but not I
 
Ca(L)
 
) and a
demonstration of its distinctness from CICR (CICR
does not require cAMP). As noted by Grifﬁths and
MacLeod (2003), cAMP is known to increase I
 
Ca(L)
 
 am-
plitude, SR Ca
 
2
 
 
 
 content, and, hence, gain. Because of
this increase in gain and the instances in which the Fer-
rier-Howlett group did not detect increases in I
 
Ca(L)
 
, it
becomes difﬁcult to assess Ferrier and Howlett’s inter-
pretation. One would need to have the Ferrier and
Howlett group’s observations replicated using the rig-
orous methods of Grifﬁths and MacLeod (2003) to as-
sess the I
 
Ca(L)
 
 amplitude.
(5) Zhu and Ferrier (2000) report that the purported
selective loss of VSRM induced by internal dialysis can
be restored by activation of Ca
 
2
 
 
 
-calmodulin–depen-
dent kinase II. That is, internal calmodulin is said to,
like cAMP, increase the contraction amplitude without
an increase in I
 
Ca(L)
 
 under VSRM-selective conditions.T
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Under CICR-selective conditions both contraction and
I
 
Ca(L)
 
 increase somewhat, presumptively demonstrating
the distinct nature of VSRM vs
 
.
 
 CICR. But again, the ev-
idence for VSRM is based entirely on the failure to de-
tect, or detect changes in, small amplitude Ca
 
2
 
 
 
 cur-
rents. Reports of such failures must remain in question
until replicated with more rigorous methods for detect-
ing small currents.
(6) Mason and Ferrier (1999) reported that tetra-
caine, which is believed to suppress SR Ca
 
2
 
 
 
 release,
strongly blocks contraction at very negative and at very
positive test potentials, with very little effect near 0 mV.
These experiments were done at a holding potential of
 
 
 
65 mV, so that the putative VSRM is available. Mason
and Ferrier (1999) interpret these ﬁndings as demon-
strating distinct VSRM and CICR processes. They at-
tribute contraction both at very negative and very posi-
tive potentials primarily to VSRM as I
 
Ca(L)
 
 amplitude is
small in these ranges. I
 
Ca(L)
 
 is maximal near 0 mV. How-
ever, Ca
 
2
 
 
 
 entry is small both at very negative and very
positive potentials, and any intervention that hinders
EC coupling would be expected to be more effective in
suppressing contraction at these potentials. That a
blocker of EC coupling is more effective in blocking
contraction at some, as compared with other, voltage
ranges is not of itself evidence for distinct EC coupling
processes.
(7) As noted above, the Ferrier and Howlett group
has reported distinct pharmacological proﬁles for
CICR as compared with the putative VSRM, which they
take as evidence for two distinct EC-coupling mecha-
nisms. The Ca channel blockers, verapamil, Cd
 
2
 
 
 
, nifed-
ipine, and Ni
 
2
 
 
 
 are said to preferentially block CICR
(Ferrier and Howlett, 1995; Hobai et al., 1997; Ferrier
et al., 1998, 2000; Howlett et al., 1998, 1999; Zhu and
Ferrier, 2000), while ryanodine, thapsigargin, and tetra-
caine are said to preferentially block VSRM (Ferrier
and Howlett, 1995; Ferrier et al., 1998; Howlett et al.,
1998; Mason and Ferrier, 1999). These attributions are
all based on whether block appears to be more effective
at more negative (ryanodine, thapsigargin, tetracaine)
or more positive (Ca
 
2
 
 
 
 channel blockers) voltage
ranges. As discussed in point 2 and by Grifﬁths and
MacLeod (2003), Ca
 
2
 
 
 
 channel block is voltage depen-
dent, being less effective at more negative potentials.
And, as discussed in point 6, a more effective block of
contraction at more negative potentials where I
 
Ca(L)
 
 is
small is not surprising. Hence, the “distinct pharmaco-
logical proﬁles” could equally well be attributed to dis-
tinct properties of the blocking agents rather than to
distinct EC coupling processes.
(8) Howlett et al. (1998) report that increased SR
Ca
 
2
 
 
 
 loading increases contraction amplitude more ef-
fectively under putative VSRM-selective conditions than
under CICR-selective conditions. They took this to sup-
port the presence of two distinct EC-coupling pro-
cesses. However, under VSRM-selective conditions the
I
 
Ca(L)
 
 whole cell current amplitude is greater (because
of the more negative holding potentials), the I
 
Ca(L)
 
 sin-
gle channel current amplitude is greater (more nega-
tive test steps) and gain is higher. Thus, CICR can fully
account for the observed effect. Again, differential ef-
fects obtained at different voltage ranges do not neces-
sarily imply distinct EC coupling processes. Howlett et
al. (1998) also report that identical contraction-voltage
curves, presumed to arise entirely from the putative
VSRM component, can be obtained by two quite sepa-
rate treatments, ryanodine exposure and reduced SR
Ca
 
2
 
 
 
 loading, which is taken as support for a genuine
VSRM process. Using a holding potential of 
 
 
 
65 mV, so
that VSRM and CICR are both available, a contraction-
voltage curve is constructed. A standard train of condi-
tioning pulses to maintain SR Ca
 
2
 
 
 
 loading is presented
before each holding potential/test step sequence. The
experiment is repeated in the presence of ryanodine,
which is said to preferentially block the VSRM compo-
nent (see point 7), and a difference contraction-voltage
curve is obtained. In the second series of experiments,
ryanodine is not used, but the amplitude of the condi-
tioning pulses is reduced so that SR Ca
 
2
 
 
 
 loading is re-
duced, which also is said to preferentially reduce
VSRM. A difference contraction-voltage curve is again
obtained. These two difference contraction-voltage
curves are virtually superimposable point for point,
which would tend to support the idea of a distinct
VSRM component. But one would need to replicate
these experiments.
(9) Howlett et al. (1999) report that in the cardiomyo-
pathic hamster model, contraction is more suppressed
under VSRM-selective than under CICR-selective condi-
tions, which is taken as evidence for a distinct VSRM
component. However, as noted in point 8, VSRM-selec-
tive conditions are exactly those where contraction is
most sensitive to changes in gain, which makes it very
difﬁcult to interpret this ﬁnding deﬁnitively.
(10) Ferrier et al. (2000) report that contractions typ-
ically express a sustained component in addition to the
usual phasic component. The sustained component is
reported to be evident over the whole range over which
phasic contractions are seen. It was interpreted to be a
VSRM-mediated process because of its relative insensi-
tivity to Cd
 
2
 
 
 
 block and because its amplitude is maxi-
mal where I
 
Ca(L)
 
 is fully inactivated. This sustained com-
ponent, however, is different from the phasic VSRM
component in that it does not inactivate. These are
again experiments that one would like to see replicated.
The same is true for the remaining two points below.
(11) Howlett et al. (1998) report that the midpoint of
the steady-state inactivation curve for the VSRM contrac-
tion component is 25–30 mV more negative than that forT
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I
 
Ca(L)
 
. The VSRM contraction is fully inactivated at poten-
tials where I
 
Ca(L)
 
 is at 90% of its maximum availability.
This ﬁnding is not obviously reconcilable with CICR.
(12) Howlett et al. (1998) also report that restitution
of the VSRM component of contraction proceeds with
a time constant nearly twofold slower than that for
I
 
Ca(L)
 
 recovery from inactivation. Hence, I
 
Ca(L)
 
 is avail-
able when VRSM-mediated contraction is not. This
ﬁnding is also not obviously reconcilable with CICR.
In conclusion, much of the evidence presented in
support of VSRM is ambiguous. A number of effects
attributed to VSRM can be equally well attributed
to CICR when unrecognized Ca
 
2
 
 
 
 currents, voltage-
dependent gain, and other issues are taken into ac-
count. Grifﬁths and MacLeod (2003) have made a clear
contribution to this question by showing that inward
Ca
 
2
 
 
 
 current does accompany contraction under con-
ditions similar to those for which some earlier reports
have said that it does not. Thus, a single EC coupling
mechanism, CICR, can account for a considerable body
of experimental observations.
It is very difﬁcult, however, to demonstrate conclu-
sively that there is no VSRM-mediated component of
EC coupling operating in parallel with CICR. The pos-
sibility must be left open. And, while the body of exper-
imental evidence apparently supporting VSRM has
been appreciably reduced by the careful experiments
of Grifﬁths and MacLeod (2003), some observations re-
main. A fuller resolution of this question will await fur-
ther experimental studies.
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